CNS therapeutics: Immune cells break the barriers
Science Translational Medicine · 2023
DOI: 10.1126/scitranslmed.adh1150 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science Translational Medicine, 2023. Verfasst von Karine Thai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Neuroimmunology Research Laboratory, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC H2X 0A9, Canada. Hauptthemen laut MEDLINE: Central Nervous System, Central Nervous System Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Peripheral immune cells can be seen as attractive vectors and drug carriers for central nervous system therapeutics because these cells have unique properties that allow them to migrate across the blood-brain barrier, enabling drug delivery to brain regions that are inaccessible to free drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neuroimmunology Research Laboratory, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC H2X 0A9, Canada.
- Department of Neuroscience, Faculty of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.
- Multiple Sclerosis Clinic, Division of Neurology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC H2L 4M1, Canada.
ORCID-Profile: Karine Thai, Alexandre Prat
Zitieren
APA
Thai, K., & Prat, A. (2023). CNS therapeutics: Immune cells break the barriers. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.adh1150
Vancouver
Thai K, Prat A. CNS therapeutics: Immune cells break the barriers. Science Translational Medicine. 2023. doi:10.1126/scitranslmed.adh1150
BibTeX
@article{Thai2023,
author = {Thai, Karine and Prat, Alexandre},
title = {CNS therapeutics: Immune cells break the barriers},
journal = {Science Translational Medicine},
year = {2023},
doi = {10.1126/scitranslmed.adh1150}
}
EUVIMED